abhishreshthaa
Abhijeet S
SWOT ANALYSIS ON Johnson & Johnson : Johnson & Johnson is a global American pharmaceutical, medical devices and consumer packaged goods manufacturer founded in 1886. Its common stock is a component of the Dow Jones Industrial Average and the company is listed among the Fortune 500. Johnson & Johnson is known for its corporate reputation, consistently ranking at the top of Harris Interactive's National Corporate Reputation Survey, ranking as the world's most respected company by Barron's Magazine, and was the first corporation awarded the Benjamin Franklin Award for Public Diplomacy by the U.S. State Department for its funding of international education programs. A suit brought by the United States Department of Justice in 2010, however, alleges that the company from 1999 to 2004 illegally marketed drugs to Omnicare, a pharmacy that dispenses the drugs in nursing homes.
The corporation's headquarters is located in New Brunswick, New Jersey, United States. Its consumer division is located in Skillman, New Jersey. The corporation includes some 250 subsidiary companies with operations in over 57 countries. Its products are sold in over 175 countries. J&J had worldwide pharmaceutical sales of $24.6 billion for the full-year 2008.
Johnson & Johnson's brands include numerous household names of medications and first aid supplies. Among its well-known consumer products are the Band-Aid Brand line of bandages, Tylenol medications, Johnson's baby products, Neutrogena skin and beauty products, Clean & Clear facial wash and Acuvue contact lenses.
Strengths
* Diversified product offerings: company operates in three segments: Consumer, Pharmaceutical, and Medical Devices and Diagnostics
* Company covers the almost the full spectrum of the supply chain (research and development, manufacture and sale of products)
* Support from non-pharmaceutical business
divisions
* Brand recognition
* Strong drug pipeline
Weaknesses
* Generic drug's exposure
* Private label exposure
* High reliance on sales of CNS and Risperdal
* Kills babies
Opportunities
* Leverage experience with therapeutic proteins and monoclonal antibodies across other therapy areasasdfasfa
* Integrate recent acquisitions
* Global expansion
Threats
* Healthcare regulations
* Private label growth; generic drugs growth
* Weaker consumer environment expected in the US
* Spreading too thinly - made investments in non-core areas, like social media
The corporation's headquarters is located in New Brunswick, New Jersey, United States. Its consumer division is located in Skillman, New Jersey. The corporation includes some 250 subsidiary companies with operations in over 57 countries. Its products are sold in over 175 countries. J&J had worldwide pharmaceutical sales of $24.6 billion for the full-year 2008.
Johnson & Johnson's brands include numerous household names of medications and first aid supplies. Among its well-known consumer products are the Band-Aid Brand line of bandages, Tylenol medications, Johnson's baby products, Neutrogena skin and beauty products, Clean & Clear facial wash and Acuvue contact lenses.
Strengths
* Diversified product offerings: company operates in three segments: Consumer, Pharmaceutical, and Medical Devices and Diagnostics
* Company covers the almost the full spectrum of the supply chain (research and development, manufacture and sale of products)
* Support from non-pharmaceutical business
divisions
* Brand recognition
* Strong drug pipeline
Weaknesses
* Generic drug's exposure
* Private label exposure
* High reliance on sales of CNS and Risperdal
* Kills babies
Opportunities
* Leverage experience with therapeutic proteins and monoclonal antibodies across other therapy areasasdfasfa
* Integrate recent acquisitions
* Global expansion
Threats
* Healthcare regulations
* Private label growth; generic drugs growth
* Weaker consumer environment expected in the US
* Spreading too thinly - made investments in non-core areas, like social media
Last edited by a moderator: